Inventiv Health Inc
| Public | |
| Industry |
Pharmaceutical Biotechnology Medical Device Clinical Research |
| Founded | 1999 |
| Headquarters | Burlington, Massachusetts, United States of America |
Key people |
Paul Meister (Chairman and CEO) Mike Bell (Chief Operating Officer) |
| Products |
biopharmaceutical product development regulatory consulting clinical trials management advanced eClinical technology solutions |
Number of employees | 12,000 |
| Website | www.inventivhealth.com |
Inventiv Health Incorporated formerly Pharmanet/i3 is an American multinational, and one of the largest contract research organization (CRO), based in Burlington, Massachusetts.[1][2] The company provides services to the pharmaceutical, biotechnology and medical device industries, including consulting, clinical studies and market launch.[3] The global CRO constitutes the Inventiv health clinical, the Inventiv health Commercial, the Inventiv Health Consulting, the Campbell Alliance, and the Adheris Health.[4] The company is spread across U.S., Europe, Japan, China, Korea and India. The company offers customized patient centric solutions through its EMBARX technology.[5][6][7]
References
- ↑ Advaxis Selects inVentiv Health Clinical To Conduct Clinical Trials Of Immunotherapy Candidates - Yahoo Finance
- ↑ inVentiv Health To Acquire Leading Management Consulting Firm, Campbell Alliance, and Global CRO Organization, i3 - FierceBiotech
- ↑ inVentiv Clinical Trial Recruitment Solutions Shares Insights On The Use Of Behavioral Science To Improve Patient Recruitment And Retention | Reuters
- ↑ Risk Assessment: Laying the Foundation for RBM
- ↑ Newsroom | inVentiv Health
- ↑ http://www.inventivhealth.com/downloads/about_us/00871_vencrp_presskit_corp_f.pdf
- ↑ inVentiv Health News, Articles and Archives | CenterWatch News Online